Plea to radiologists: Please consider Mahvash disease when encountering an enlarged pancreas

Radiologists play a key role in establishing an early and accurate diagnosis, especially for rare diseases. Mahvash disease (OMIM 619290) is an autosomal recessive hereditary disease caused by inactivating mutations of the glucagon receptor and its main clinical consequences are pancreatic neuroendo...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of radiology Vol. 16; no. 8; pp. 371 - 374
Main Author Yu, Run
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 28.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Radiologists play a key role in establishing an early and accurate diagnosis, especially for rare diseases. Mahvash disease (OMIM 619290) is an autosomal recessive hereditary disease caused by inactivating mutations of the glucagon receptor and its main clinical consequences are pancreatic neuroendocrine tumors and in some cases, porto-sinusoidal vascular disease and portal hypertension. Untreated Mahvash disease can be lethal. The diagnosis of Mahvash disease has almost always been delayed in the past due to radiologists' unawareness of or unfamiliarity with the unique imaging features of Mahvash disease which are moderately to enormously enlarge pancreas with preserved pancreas contour and parenchyma without vascular involvement or lymphadenopathy. These features help differentiate Mahvash disease from other etiologies of diffusely enlarged pancreas such as diffuse pancreatic ductal carcinoma, diffuse pancreatic lymphoma, and autoimmune pancreatitis. Invoking Mahvash disease in the differential diagnosis of an enlarged pancreas has recently been shown to facilitate early diagnosis. To prevent missing the diagnosis of this significant disease, I sincerely ask radiologists to consider Mahvash disease in their differential diagnoses of diffusely enlarged pancreas.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: Yu R wrote the paper.
Corresponding author: Run Yu, MD, PhD, Professor, Division of Endocrinology, Diabetes, and Metabolism, University of California at Los Angeles, David Geffen School of Medicine, 200 Medical Plaza Driveway 530, Los Angeles, CA 90095, United States. runyu@mednet.ucla.edu
ISSN:1949-8470
1949-8470
DOI:10.4329/wjr.v16.i8.371